Lyscost Tablet contains Lynestrenol 0.5 mg, a synthetic progestogen used primarily in the management of gynecological disorders. It is indicated for the treatment of menstrual irregularities, secondary amenorrhea, dysmenorrhea, and endometriosis. Lynestrenol exerts its therapeutic effect by modulating the hormonal milieu, thereby regulating the menstrual cycle and reducing endometrial proliferation. This action helps alleviate symptoms associated with hormonal imbalances such as abnormal uterine bleeding and pelvic pain. Additionally, Lyscost Tablet is utilized in hormone replacement therapy and as a component in contraceptive regimens. The drug is administered orally, with dosage and duration tailored according to the specific condition and patient response. Common adverse effects may include nausea, headache, breast tenderness, and changes in menstrual patterns. Contraindications include known hypersensitivity to Lynestrenol or other progestogens, active thromboembolic disorders, liver dysfunction, and hormone-dependent malignancies. Caution is advised in patients with a history of cardiovascular disease or diabetes. Regular monitoring by a healthcare professional is recommended to assess therapeutic efficacy and detect any potential adverse reactions. Lyscost Tablet should be used under medical supervision to ensure safe and effective treatment outcomes.